Ravelcare Limited
BBSE:RAVEL92.45
INR
+9.45
(+11.39%)
ISIN
INE0W4D01018
Return %
Stock
S&P 500
1Y
- -
14.20
3Y
- -
81.12
5Y
- -
68.34
Capital Structure
INR
•
in mil. unless spec.Working Capital
INR
•
in mil. unless spec.Growth Rates
INR
•
in mil. unless spec.Semi-annual Revenue
INR
•
in mil. unless spec.Semi-annual Earnings Per Share
INR
•
in mil. unless spec.Semi-annual Dividends Per Share
INR
•
in mil. unless spec.Company Description
- CEO
- Ayush Mahesh Varma
- Full Time Employees
- 23
- Sector
- Consumer non-durables
- Industry
- Household/Personal care
- Address
- Mumbai India
- IPO Date
- Dec 8, 2025
- Website
- ravelcare.com
- Similar Companies
- Business
- Ravelcare Limited is an India-based healthcare and wellness enterprise engaged in the development, manufacturing, marketing, and commercialization of pharmaceutical formulations, consumer healthcare solutions, personal care products, and specialized wellness goods. The Company operates through key business segments comprising Pharmaceuticals, Consumer Healthcare, and Dermatological Care. Its comprehensive product and service portfolio includes prescription pharmaceuticals across therapeutic categories such as anti-infectives, analgesics, gastrointestinal treatments, and respiratory medications; over-the-counter healthcare solutions, including dietary supplements, multivitamin complexes, immunity boosters, and herbal formulations; personal care and dermatological products encompassing therapeutic skincare creams, medicated cleansers, dermatological lotions, anti-aging serums, and hair care treatments; as well as contract formulation development and third-party manufacturing services for institutional healthcare partners. Ravelcare Limited distributes its offerings across domestic and international markets through a multi-channel network serving retail pharmacies, hospitals, clinics, healthcare institutions, wholesale distributors, and digital e-commerce platforms. The Company was founded in India and maintains its corporate headquarters in Mumbai, Maharashtra, India. In recent corporate developments, Ravelcare Limited has executed a strategic corporate restructuring and brand expansion to strengthen its presence in high-growth dermatology and preventive wellness segments; established strategic distribution partnerships with modern retail pharmacy chains and digital health platforms to broaden its geographic reach; upgraded its manufacturing infrastructure to enhance production capacity in compliance with updated Good Manufacturing Practices standards; and introduced an expanded line of specialized derma-cosmetics and clinical-grade nutraceutical products to address evolving consumer demand.